Division of Hematology & Thromboembolism
Research Overview
The Division of Hematology and Thromboembolism has an International
reputation for the quality and impact of its research. Research foci
include the study of venous and arterial thromboembolism, clinical trials
in malignant hematology and a developing Transfusion Medicine Research
Program.
The Clinical Thromboembolism Research Program is coordinated by the Thrombosis and Atherosclerosis Research Institute (TaARI); an important component of this program is the St Joseph’s Healthcare Vascular Medicine Research Program.
Research into malignant Hematology is coordinated out of the Juravinski Cancer Centre, the Department of Pathology and Molecular Medicine and the National Cancer Institute of Canada (link). The McMaster Transfusion Research Program (Directed by Ms. Nancy Heddle ) is becoming a National Leader in Transfusion Medicine Research.
The Henderson Research Centre (HRC) was established in 1988 as a joint initiative of the Hamilton Health Sciences and McMaster University. Initially, there were two programs, Experimental Thrombosis and Atherosclerosis (ETA) and Clinical Trials Methodology (CTM), both of which were located in a temporary facility at the Henderson General Division.
In 1992, a third program, the Preventive Cardiology and Therapeutics (PCT), was added to the Research Centre.
In 1994, the Clinical Thromboembolism Program (CTE) was launched. The programs span the spectrum of research in cardiovascular medicine, thrombosis and atherosclerosis.
